- Home
- FBRT vs ORIC Comparison
FBRT vs ORIC Comparison
Compare FBRT & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FBRT | ORIC |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 882.8M | 783.0M |
| IPO Year | 1985 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FBRT | ORIC |
|---|---|---|
| Price | $10.45 | $8.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 12 |
| Target Price | $14.33 | ★ $19.50 |
| AVG Volume (30 Days) | 741.0K | ★ 1.5M |
| Earning Date | 02-12-2026 | 11-13-2025 |
| Dividend Yield | ★ 13.54% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.80 | N/A |
| Revenue | ★ $241,051,000.00 | N/A |
| Revenue This Year | $28.41 | N/A |
| Revenue Next Year | $50.77 | N/A |
| P/E Ratio | $13.13 | ★ N/A |
| Revenue Growth | ★ 32.77 | N/A |
| 52 Week Low | $9.71 | $3.90 |
| 52 Week High | $13.58 | $14.93 |
Technical Indicators
Market Signals| Indicator | FBRT | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 48.55 | 27.80 |
| Support Level | $10.42 | $7.98 |
| Resistance Level | $10.58 | $8.62 |
| Average True Range (ATR) | 0.15 | 0.59 |
| MACD | -0.02 | -0.07 |
| Stochastic Oscillator | 6.25 | 6.52 |
Price Performance
Historical ComparisonAbout FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. Its segments include the real estate debt business; the real estate securities business; the real estate owned business; and the commercial real estate conduit business.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.